Paris, May 19, 2015 – Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque™ (iodixanol) than those using low-osmolar contrast media (LOCM), demonstrate data from abstracts presented today at the EuroPCR Congress 2015 in Paris.
http://www.genewsroom.com/press-releases/using-isosmolar-contrast-agent-during-angioplasty-reduces-risk-renal-and-cardiac